Abstract
Niemann-Pick type C disease (NPC) is a rare inherited neurodegenerative disorder characterized by an accumulation of intracellular cholesterol within late endosomes and lysosomes due to NPC1 or NPC2 dysfunction. In this work, we tested the hypothesis that retromer impairment may be involved in the pathogenesis of NPC and may contribute to increased amyloidogenic processing of APP and enhanced BACE1-mediated proteolysis observed in NPC disease. Using NPC1-null cells, primary mouse NPC1-deficient neurons and NPC1-deficient mice (BALB/cNctr-Npc1m1N), we show that retromer function is impaired in NPC. This is manifested by altered transport of the retromer core components Vps26, Vps35 and/or retromer receptor sorLA and by retromer accumulation in neuronal processes, such as within axonal swellings. Changes in retromer distribution in NPC1 mouse brains were observed already at the presymptomatic stage (at 4-weeks of age), indicating that the retromer defect occurs early in the course of NPC disease and may contribute to downstream pathological processes. Furthermore, we show that cholesterol depletion in NPC1-null cells and in NPC1 mouse brains reverts retromer dysfunction, suggesting that retromer impairment in NPC is mechanistically dependent on cholesterol accumulation. Thus, we characterized retromer dysfunction in NPC and propose that the rescue of retromer impairment may represent a novel therapeutic approach against NPC.
Highlights
Licensee MDPI, Basel, Switzerland.It is well established that changes in the endolysosomal system are linked to both the most common, as well as rare, inherited neurodegenerative diseases (NDs), indicating that maintaining endolysosomal homeostasis is important for brain cell function [1,2,3,4]
Retromer dysfunction is linked to several neurodegenerative disorders, including the most common Alzheimer’s disease (AD) and Parkinson’s disease (PD) [11]
Α-synuclein and tau), loss of synapses, neuronal dysfunction and neuroinflammation [54]. Since all these features are characteristic of a rare lipid storage and neurodegenerative disorder Niemann-Pick type C (NPC), in this work, we analyzed if retromer traffickingfunction is involved in the pathogenesis of Niemann-Pick type C disease (NPC) disease
Summary
(cathepsin D, or CTSD)) [13] It seems that retromer dysfunction is a shared feature among multiple neurodegenerative diseases and that retromer targeting could be a valuable common approach against NDs. Several retromer stabilizing agents, reduced key pathological features of AD and ALS, including Aβ and tau pathology, neuronal loss, memory and locomotor impairment, respectively [12,29,30,31].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.